Travel Vaccines Market to Reach $5.91 Billion, Globally, by 2028 at 9.8% CAGR: The Insight Partners

NEW YORK, April 6, 2022 /PRNewswire/ -- The Insight Partners published latest research study on "Travel Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Hepatitis A, Hepatitis B, Meningococcal Vaccines, DPT, Yellow Fever, Typhoid, Japanese Encephalitis, Measles Mumps & Rubella, Rabies, Polio, Influenza, Varicella & Shingles, Cholera, and Others) and Application (Domestic Travel and Outbound Travel)", the global travel vaccines market is projected to reach $5.91 Billion by 2028 from $3.07 Billion in 2021; it is estimated to grow at a CAGR of 9.8% from 2021 to 2028.

The travel vaccines market growth is driven by the rapid growth in the travel and tourism sector and the increasing need to prevent transnational infections globally. However, the high cost of travel vaccines hinders the market's growth.

Get Exclusive Access to Sample Pages of Travel Vaccines Market Size - COVID-19 Impact and Global Analysis with Strategic Insights at: https://www.theinsightpartners.com/sample/TIPRE00007439/

Travel Vaccines Market: Competition Landscape and Key Developments

GlaxoSmithKline plc; Merck & Co., Inc.; Sanofi; Novartis AG; Pfizer Inc.; Dynavax Technologies; Emergent BioSolutions Inc.; Abbott; Bharat Biotech; and Valneva SE are the key companies operating in the travel vaccines market. Companies adopt product innovation strategies to meet the evolving customer demands worldwide, permitting them to maintain their brand name in the global travel vaccines market. Also, market players create partnerships, collaborations, and contracts with hospitals and other healthcare facilities at various levels, such as municipal, state, and commercial, to improve emergency services, driving the travel vaccines market growth.

In December 2021, Emergent BioSolutions Inc. announced the first participant dosed in its phase 1 study, EBS-UFV-001, evaluating the safety, tolerability, and immunogenicity of its investigational universal influenza vaccine candidate. The current version of the influenza vaccine candidate contains multiple components intended to induce broad and supra-seasonal immunity against influenza A viruses.

Place Your Inquiry Before Buying: https://www.theinsightpartners.com/inquiry/TIPRE00007439/

In June 2021, Merck & Co., Inc. and Sanofi developed the Vaxelis vaccine (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate, and Hepatitis B Vaccine) as part of a US-based partnership between the companies. The vaccine is considered the first hexavalent combination vaccine available in the US indicated for active immunization to help prevent DTP, polio, and hepatitis B.

Travel vaccines, also called travel immunizations, are shots travelers can get before visiting certain areas of the world, which help protect them from serious illnesses common in those ahead. Travel vaccines are safe, effective ways to help protect travelers from bringing home more infections than expected. These vaccines are recommended to protect against diseases endemic to the country of origin or destination. They are intended to protect travelers and prevent disease spread within and between countries.

Some countries require proof of vaccination for travelers, wishing to enter or exit the country. The continuous rise in the tourism industry and the increasing prevalence of infectious diseases contribute to the market's progress. However, the high cost of these vaccines has limited their demand, hindering the market.

A few vaccines are related to various diseases, such as hepatitis A, hepatitis B, meningococcal infections, diphtheria pertussis tetanus (DPT), yellow fever typhoid, Japanese encephalitis, measles mumps & rubella, rabies, polio, influenza, varicella & shingles, and cholera. The hepatitis A vaccination is expected to fuel the demand for travel vaccines substantially in the near future. Also, the DPT and influenza vaccines are projected to see significant growth during the forecast period, further driving the travel vaccine market growth.

Travel and tourism have become an integral part of the human lifestyle. Improving economic conditions and a change in the ongoing routine of people has also offered opportunities to explore a different culture, tradition, spiritualism, rural and ethnic tourism, wellness and health holidays, and many more across the world. According to The Millennial Travel Study by Skyscanner, 80% of respondents preferred traveling to international destinations over domestic ones. Over ~1,000 millennials (aged 18-35) were quizzed on factors, such as their preferred destination, mode of travel, and interests. Skyscanner also noted European destinations are a firm favorite among travelers of all age groups, followed by the US and New Zealand.

Connect With Our Research Analyst On: https://www.theinsightpartners.com/speak-to-analyst/TIPRE00007439

Additionally, Statistics from Our World in Data, which collected the data from the World Tourism Organization, showed an increase in tourism in various regions in 2019—the European Union saw ~966.44 million arrivals, North America saw ~200 million arrivals, and the Middle East & North Africa saw ~128 million arrivals.

Furthermore, arrivals in France stood at 212 million in 2019, while other European countries, such as Spain, saw 126.17 million arrivals in the same year. Also, in 2019, the international number of arrivals stood at 2.403 billion. By region, the European Union saw an estimated arrival of 966.44 million, while East Asia & Pacific had 487.08 million visitors in 2019. The estimated expenditure stood at US$ 1.439 billion in international tourism.

While the COVID-19 pandemic massively disrupted this trend, the rollout of anti-COVID-19 vaccinations and COVID-19 regulations for safe traveling is expected to aid the normalization of tourism and travel. During the travel, a traveler is at risk of contracting regional diseases, leading to transnational disease outbreaks/epidemics. Thus, traveling outside the country requires immunization as a safety and precautionary measure to avoid the spread of infections.

Various countries have policies to protect their citizens from travel-associated infections. For instance, the UK National Health Service (NHS) organizes routine immunization or vaccination schedule for its citizens. If a person is traveling outside the UK, they need to get vaccinated to prevent infectious diseases such as hepatitis A, typhoid, and yellow fever. Similarly, in Saudi Arabia, travelers coming from Hajj and Umrah pilgrimages must show proof of vaccination for meningitis and seasonal influenza. Various countries require mandatory vaccination proofs documented on an International Certificate of Vaccination or Prophylaxis (ICVP).

Buy Premium Copy of Travel Vaccines Market Size, Share, Revenue, Strategic Insights and Forecasts 2021-2028 Research Report at: https://www.theinsightpartners.com/buy/TIPRE00007439/ 

Vaccination is necessary against the diseased mentioned in the US Department of Health & Human Services (HHS), such as chickenpox, cholera, COVID-19, diphtheria, influenza, Hepatitis A, Hepatitis B, Haemophilus influenzae type B, human papillomavirus, Japanese encephalitis, measles, meningococcal, mumps, pneumococcal, polio, rabies, rotavirus, rubella, shingles, tetanus, typhoid fever, whooping cough, and yellow fever, depending on the traveling country. Concerns regarding the spread of regional diseases across nations are boosting the demand for travel vaccines, thereby driving the market. Additionally, the rising trend of emergence and re-emergence of infectious diseases and their spread through travel is expected to drive the growth of the travel vaccines market.

Browse Adjoining Reports:

Live Vaccines Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Type ( Bacterial, Viral); Route of Administration ( Oral, Intravenous, Subcutaneous, Others ); Application ( Mumps, Rubella, Varicella, Yellow Fever, Rotavirus, BCG, Others ); Patient Type ( Adult, Pediatric )

Hepatitis Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Indication (Hepatitis A, Hepatitis B, Hepatitis C); Vaccine Type (Recombinant Vaccine, Inactivated Vaccine); Distribution Channel (Hospitals, Retail Pharmacy, Online Pharmacy)

Meningococcal Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Quadrivalent Vaccines, Bivalent Vaccines, Serogroup A, Serogroup B, Serogroup X); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and Geography

Vaccines And Vaccination Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Technology ( Recombinant and Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Others ); Indication ( Pneumococcal Disease, Influenza, Human Papilloma Virus, Meningococcal Disease, Rotavirus, Varicella, Diphtheria, Polio, Hepatitis, Other Indications ); End User ( Pediatric, Adults, Travelers)

Meningococcal Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Bivalent, Quadrivalent, Others); Brand (Menactra, Menveo, Bexsero, Trumenba, Nimenrix, Others)

Meningitis Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Vaccine Type (Haemophilus influenza type b vaccine, pneumococcal conjugate vaccine, pneumococcal polysaccharide vaccine, meningococcal vaccine, others); Distribution Channel (hospital pharmacies, retail pharmacies, others)

Meningococcal Disease Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Antibiotics, Vaccines); Application (Hospital, Clinics, Others) and Geography

Typhoid Fever Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine, Others); Route of administration (Oral, Injectable), and Geography.

Infectious Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Inactivated Vaccines, Live Attenuated Vaccines, DNA and Recombinant Vector Vaccines, Others); Disease (Typhoid, Tuberculosis, Tetanus and Diphtheria, Influenza, Hepatitis, Polio, Others); Distribution Channel (Hospitals and Retail Pharmacies, Online Distribution), and Geography

Measles vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Mumps Measles Rubella Vaccine, Live (MMR-II), Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)); Application (Children, Adults)

Measles Mumps and Rubella Virus Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monovalent, Combination); End User (Hospital, Healthcare Centers, Others), and Geography

Oral Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type (Live vaccine, Inactive Vaccine, Recombinant Vaccine, Others); Application (Polio, Rabies, Tuberculosis, Influenza, Respiratory infections, HIV, Others); End User (Hospitals, Government vaccination programs, Research institutes, Others) and Geography

Polio Vaccine Market Forecast to 2028 - Covid-19 Impact and Global Analysis - by Type (Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)); Application (Public, Private)

Poliomyelitis Vaccine in Dragee Candy Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type (Viruses I, Viruses II, Viruses III); End-User (Hospital, Clinic, Medical Center)

Avian influenza vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Vaccine Type (inactivated vaccines, live recombinant vaccines, combination vaccines); Strain (H5 strain, H7 strain, H9 strain); Application (chicken, duck and goose, others.)

Chickenpox Vaccine Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine (Monovalent Varicella Vaccine, Combination Varicella Vaccine); Application (Kids Injection, Adults Injection)

Adult Vaccines Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Type (Preventive Vaccine, Therapeutic Vaccine); Disease (Influenza, Meningococcal, Zoster Shingles, Pneumococcal,Diphtheria, Tetanus, Pertussis (DTP), Hepatitis, Measles, Mumps, Rubella and Varicella (MMRV)); Technology (Non-Live Attenuated Vaccines, Inactivated Viral/Bacterial Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines) and Geography

Cholera Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Dukoral, Shanchol, Vaxchora, Euvichol and Others); End User (Hospitals and Clinics, Research and Academic Laboratories, Others) and Geography

Whole Cell Cholera Vaccine Market Forecast to 2028 - Covid-19 Impact and Global Analysis By Type (Adult, Children); End User (Clinical Research Institutes, Hospital, Surgical Centers.) and Geography

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please contact us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/travel-vaccines-market

Logo: https://mma.prnewswire.com/media/1586348/The_Insight_Partners_Logo.jpg